Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Acute Myeloid Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT04321161
What this trial is testing

Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment

Who this might be right for
Acute Myeloid Leukemia, in Relapse
University of Freiburg 10
Large-scale testing (Phase 3)Study completedNCT00317642
What this trial is testing

Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)

Who this might be right for
Acute Myelogenous Leukemia
Genzyme, a Sanofi Company 326
Not applicableEnded earlyNCT05224661
What this trial is testing

Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

Who this might be right for
Acute Myeloid Leukemia in Remission
Center for International Blood and Marrow Transplant Research 303
Early research (Phase 1)Looking for participantsNCT05924750
What this trial is testing

BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Sichuan Baili Pharmaceutical Co., Ltd. 130
Early research (Phase 1)Study completedNCT02914977
What this trial is testing

Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myeloid Leukemia
Tara Lin 18
Not applicableEnrolling By InvitationNCT05332054
What this trial is testing

Long-Term Follow-up Study

Who this might be right for
Lymphoma, Non-HodgkinRelapsed Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+7 more
Caribou Biosciences, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT05211570
What this trial is testing

AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in RelapseMyelodysplastic Syndrome Acute Myeloid Leukemia
AB Science 78
Testing effectiveness (Phase 2)Study completedNCT00795769
What this trial is testing

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more
Fred Hutchinson Cancer Center 49
Not applicableUnknownNCT02192619
What this trial is testing

National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

Who this might be right for
Newly-diagnosed APL (de Novo or Therapy-related)Relapsed APL
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 500
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Early research (Phase 1)Ended earlyNCT00101231
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 88
Testing effectiveness (Phase 2)UnknownNCT03080922
What this trial is testing

High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

Who this might be right for
Leukemia, Myeloid
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10
Early research (Phase 1)WithdrawnNCT02215629
What this trial is testing

Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Verastem, Inc.
Early research (Phase 1)Looking for participantsNCT04375631
What this trial is testing

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic Syndrome+6 more
Fred Hutchinson Cancer Center 120
Early research (Phase 1)Active Not RecruitingNCT05146739
What this trial is testing

Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane

Who this might be right for
Acute Myeloid Leukemia Post Cytotoxic TherapyMyelodysplastic Syndrome Post Cytotoxic TherapyMyeloid Leukemia Associated With Down Syndrome+6 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT06131801
What this trial is testing

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Who this might be right for
Hematologic MalignancyLeukemiaLymphoma+16 more
Children's Hospital Medical Center, Cincinnati 30
Early research (Phase 1)Study completedNCT03144245
What this trial is testing

Study of AMV564 in Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Amphivena Therapeutics, Inc. 53
Early research (Phase 1)Ended earlyNCT00103272
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more
National Cancer Institute (NCI) 74
Early research (Phase 1)Looking for participantsNCT05949125
What this trial is testing

Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies (1b Dose Expansion)

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
AvenCell Europe GmbH 37
Early research (Phase 1)Ended earlyNCT04702425
What this trial is testing

VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma)

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Acute Myeloid Leukemia (AML)Multiple Myeloma (MM)
Novartis Pharmaceuticals 37
Next Page
8